A mitochondrial-targeted nitroxide is a potent inhibitor of ferroptosis

ACS Central Science

Volumn 2, Issue 9, 2016, Pages 653-659

  Krainz, Tanja ^a   Gaschler, Michael M ^b   Lim, Chaemin ^a   Sacher, Joshua R ^a   Stockwell, Brent R ^b   Wipf, Peter ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CELL DEATH; LIPIDS; OXIDATION;

CELL-DEATH PATHWAYS; LIPID OXIDATION; LIPID PEROXIDATION; ORDERS OF MAGNITUDE; POTENT INHIBITOR; PROBE STRUCTURES; REACTIVE OXYGEN SPECIES; SUBCELLULAR LOCALIZATIONS;

MITOCHONDRIA;

EID: 85012284181     PISSN: 23747943     EISSN: 23747951     Source Type: Journal    
DOI: 10.1021/acscentsci.6b00199     Document Type: Article

References (31)

1. Aki, T.; Funakoshi, T.; Uemura, K. Regulated necrosis and its implications in toxicology. Toxicology 2015, 333, 118-126.
2. Conrad, M.; Friedmann Angeli, J. P.; Vandenabeele, P.; Stockwell, B. R. Regulated necrosis: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discovery 2016, 15, 348-366.
3. Dixon, S. J.; Lemberg, K. M.; Lamprecht, M. R.; Skouta, R.; Zaitsev, E. M.; Gleason, C. E.; Patel, D. N.; Bauer, A. J.; Cantley, A. M.; Yang, W. S.; Morrison, B.; Stockwell, B. R. Ferroptosis: An irondependent form of nonapoptotic cell death. Cell 2012, 149, 1060-1072.
4. Conrad, M.; Friedmann Angeli, J. P. Glutathione peroxidase 4 (Gpx4) and ferroptosis: What's so special about it? Mol. Cell. Oncol. 2015, 2, e995047.
5. Dixon, S. J.; Stockwell, B. R. The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 2014, 10, 9-17.
6. Yang, W. S.; SriRamaratnam, R.; Welsch, M. E.; Shimada, K.; Skouta, R.; Viswanathan, V. S.; Cheah, J. H.; Clemons, P. A.; Shamji, A. F.; Clish, C. B.; Brown, L. M.; Girotti, A. W.; Cornish, V. W.; Schreiber, S. L.; Stockwell, B. R. Regulation of ferroptotic cancer cell death by Gpx4. Cell 2014, 156, 317-331.
7. Friedmann Angeli, J. P.; Schneider, M.; Proneth, B.; Tyurina, Y. Y.; Tyurin, V. A.; Hammond, V. J.; Herbach, N.; Aichler, M.; Walch, A.; Eggenhofer, E.; Basavarajappa, D.; Rådmark, O.; Kobayashi, S.; Seibt, T.; Beck, H.; Neff, F.; Esposito, I.; Wanke, R.; Förster, H.; Yefremova, O.; Heinrichmeyer, M.; Bornkamm, G. W.; Geissler, E. K.; Thomas, S. B.; Stockwell, B. R.; O'Donnell, V. B.; Kagan, V. E.; Schick, J. A.; Conrad, M. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 2014, 16, 1180-1191.
8. Abrams, R. P.; Carroll, W. L.; Woerpel, K. A. Five-membered ring peroxide selectively initiates ferroptosis in cancer cells. ACS Chem. Biol. 2016, 11, 1305-1312.
9. Xie, Y.; Song, X.; Sun, X.; Huang, J.; Zhong, M.; Lotze, M. T.; Zeh, H. J.; Kang, R.; Tang, D. Identification of baicalein as a ferroptosis inhibitor by natural product library screening. Biochem. Biophys. Res. Commun. 2016, 473, 775-780.
10. Yang, W. S.; Stockwell, B. R. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016, 26, 165-176.
11. Wipf, P.; Xiao, J.; Jiang, J.; Belikova, N. A.; Tyurin, V. A.; Fink, M. P.; Kagan, V. E. Mitochondrial targeting of selective electron scavengers: Synthesis and biological analysis of hemigramicidin-tempo conjugates. J. Am. Chem. Soc. 2005, 127, 12460-12461.
12. Jiang, J.; Kurnikov, I.; Belikova, N. A.; Xiao, J.; Zhao, Q.; Amoscato, A. A.; Braslau, R.; Studer, A.; Fink, M. P.; Greenberger, J. S.; Wipf, P.; Kagan, V. E. Structural requirements for optimized delivery, inhibition of oxidative stress, and antiapoptotic activity of targeted nitroxides. J. Pharmacol. Exp. Ther. 2007, 320, 1050-1060.
13. Jiang, J.; Belikova, N. A.; Hoye, A. T.; Zhao, Q.; Epperly, M. W.; Greenberger, J. S.; Wipf, P.; Kagan, V. E. A mitochondria-targeted nitroxide/hemigramicidin S conjugate protects mouse embryonic cells against gamma irradiation. Int. J. Radiat. Oncol., Biol., Phys. 2008, 70, 816-825.
14. Rwigema, J.-C. M.; Beck, B.; Wang, W.; Doemling, A.; Epperly, M. W.; Shields, D.; Goff, J. P.; Franicola, D.; Dixon, T.; Frantz, M.-C.; Wipf, P.; Tyurina, Y.; Kagan, V. E.; Wang, H.; Greenberger, J. S. Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigators. Int. J. Radiat. Oncol., Biol., Phys. 2011, 80, 860-868.
15. Shinde, A.; Berhane, H.; Rhieu, B. H.; Kalash, R.; Xu, K.; Goff, J.; Epperly, M. W.; Franicola, D.; Zhang, X.; Dixon, T.; Shields, D.; Wang, H.; Wipf, P.; Parmar, K.; Guinan, E.; Kagan, V.; Tyurin, V.; Ferris, R. L.; Zhang, X.; Li, S.; Greenberger, J. S. Intraoral mitochondrial-targeted GS-nitroxide, JP4-039, radioprotects normal tissue in tumor-bearing radiosensitive Fancd2(-/-) (c57bl/6) mice. Radiat. Res. 2016, 185, 134-150.
16. Ji, J.; Kline, A. E.; Amoscato, A.; Samhan-Arias, A. K.; Sparvero, L. J.; Tyurin, V. A.; Tyurina, Y. Y.; Fink, B.; Manole, M. D.; Puccio, A. M.; Okonkwo, D. O.; Cheng, J. P.; Alexander, H.; Clark, R. S. B.; Kochanek, P. M.; Wipf, P.; Kagan, V. E.; Bayir, H. Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat. Neurosci. 2012, 15, 1407-1413.
17. Ji, J.; Baart, S.; Vikulina, A. S.; Clark, R. S. B.; Anthonymuthu, T. S.; Tyurin, V. A.; Du, L.; St Croix, C. M.; Tyurina, Y. Y.; Lewis, J.; Skoda, E. M.; Kline, A. E.; Kochanek, P. M.; Wipf, P.; Kagan, V. E.; Bayir, H. Deciphering of mitochondrial cardiolipin oxidative signaling in cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab. 2015, 35, 319-328.
18. Xun, Z.; Rivera-Sanchez, S.; Ayala-Pena, S.; Lim, J.; Budworth, H.; Skoda, E. M.; Robbins, P. D.; Niedernhofer, L. J.; Wipf, P.; McMurray, C. T. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of huntington's disease. Cell Rep. 2012, 2, 1137-1142.
19. Escobales, N.; Nunez, R. E.; Jang, S.; Parodi-Rullan, R.; Ayala-Pena, S.; Sacher, J. R.; Skoda, E. M.; Wipf, P.; Frontera, W.; Javadov, S. Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats. J. Mol. Cell. Cardiol. 2014, 77, 136-146.
20. LogP values were calculated with Instant JChem 15.8.31.0 (ChemAxon; http://www.chemaxon.com).
21. Sprachman, M. M.; Wipf, P. A bifunctional dethylsulfoxide substitute enhances the aqueous solubility of small organic molecules. Assay Drug Dev. Technol. 2012, 10, 269-277.
22. Skoda, E. M.; Sacher, J. R.; Kazancioglu, M. Z.; Saha, J.; Wipf, P. An uncharged oxetanyl sulfoxide as a covalent modifier for improving aqueous solubility. ACS Med. Chem. Lett. 2014, 5, 900-904.
23. Xiao, J.; Weisblum, B.; Wipf, P. Trisubstituted (E)-alkene dipeptide isosteres as β-turn promoters in the gramicidin S cyclodecapeptide scaffold. Org. Lett. 2006, 8, 4731-4734.
24. Nair, R. V.; Baravkar, S. B.; Ingole, T. S.; Sanjayan, G. J. Synthetic turn mimetics and hairpin nucleators: Quo vadimus? Chem. Commun. 2014, 50, 13874-13884.
25. Beck, J. G.; Chatterjee, J.; Laufer, B.; Kiran, M. U.; Frank, A. O.; Neubauer, S.; Ovadia, O.; Greenberg, S.; Gilon, C.; Hoffman, A.; Kessler, H. Intestinal permeability of cyclic peptides: Common key backbone motifs identified. J. Am. Chem. Soc. 2012, 134, 12125-12133.
26. Gray, R. A.; Vander Velde, D. G.; Burke, C. J.; Manning, M. C.; Middaugh, C. R.; Borchardt, R. T. Delta-sleep-inducing peptide: Solution conformational studies of a membrane-permeable peptide. Biochemistry 1994, 33, 1323-1331.
27. Xiao, J.; Weisblum, B.; Wipf, P. Electrostatic versus steric effects in peptidomimicry: Synthesis and secondary structure analysis of gramicidin S analogues with (E)-alkene peptide isosteres. J. Am. Chem. Soc. 2005, 127, 5742-5743.
28. Frantz, M.-C.; Pierce, J. G.; Pierce, J. M.; Kangying, L.; Qingwei, W.; Johnson, M.; Wipf, P. Large-scale asymmetric synthesis of the bioprotective agent JP4-039 and analogs. Org. Lett. 2011, 13, 2318-2321.
29. Di, L. Strategic approaches to optimizing peptide ADME properties. AAPS J. 2015, 17, 134-143.
30. Yagoda, N.; von Rechenberg, M.; Zaganjor, E.; Bauer, A. J.; Yang, W. S.; Fridman, D. J.; Wolpaw, A. J.; Smukste, I.; Peltier, J. M.; Boniface, J. J.; Smith, R.; Lessnick, S. L.; Sahasrabudhe, S.; Stockwell, B. R. RAS-RAF-MEK-dependent oxidative cell death involving voltagedependent anion channels. Nature 2007, 447, 865-869.
31. Skouta, R.; Dixon, S. J.; Wang, J.; Dunn, D. E.; Orman, M.; Shimada, K.; Rosenberg, P.; Lo, D.; Weinberg, J.; Linkermann, A.; Stockwell, B. R. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 2014, 136, 4551-4556.